CY1466A - Galenic compositions comprising calcitonin and their use - Google Patents

Galenic compositions comprising calcitonin and their use

Info

Publication number
CY1466A
CY1466A CY146689A CY146689A CY1466A CY 1466 A CY1466 A CY 1466A CY 146689 A CY146689 A CY 146689A CY 146689 A CY146689 A CY 146689A CY 1466 A CY1466 A CY 1466A
Authority
CY
Cyprus
Prior art keywords
calcitonin
galenic compositions
galenic
compositions
Prior art date
Application number
CY146689A
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838320865A external-priority patent/GB8320865D0/en
Priority claimed from GB838322528A external-priority patent/GB8322528D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of CY1466A publication Critical patent/CY1466A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CY146689A 1982-10-05 1989-07-21 Galenic compositions comprising calcitonin and their use CY1466A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB8228390 1982-10-05
GB8236928 1982-12-30
GB838320865A GB8320865D0 (en) 1983-08-03 1983-08-03 Organic compounds
GB838322528A GB8322528D0 (en) 1983-08-22 1983-08-22 Organic compounds
GB08326436A GB2127689B (en) 1982-10-05 1983-10-03 Calcitonin inhalation compositions

Publications (1)

Publication Number Publication Date
CY1466A true CY1466A (en) 1989-07-21

Family

ID=27516489

Family Applications (1)

Application Number Title Priority Date Filing Date
CY146689A CY1466A (en) 1982-10-05 1989-07-21 Galenic compositions comprising calcitonin and their use

Country Status (2)

Country Link
CY (1) CY1466A (en)
GB (1) GB2127689B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
JPS61267528A (en) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd Transnasal calcitonin agent containing absorbefacient
JPS61194034A (en) * 1985-02-25 1986-08-28 Teijin Ltd Powdery composition for transnasal administration
JPH0651637B2 (en) 1985-03-28 1994-07-06 エーザイ株式会社 Peptide adsorption prevention composition
HU198626B (en) * 1986-05-27 1989-11-28 Sandoz Ag Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient
AT396870B (en) * 1986-08-07 1993-12-27 Sandoz Ag Process for the production of a pharmaceutical formulation for the nasal administration of serotonin antagonists
ES2061688T3 (en) * 1987-11-13 1994-12-16 Smithkline Beecham Farma PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A CALCITONINE AND A GLICIRRICINATE AS IMPROVER OF ABSORPTION.
NO179479C (en) * 1988-03-11 1996-10-16 Teikoku Seiyaku Kk Process for the preparation of an intravaginal pharmaceutical preparation
US5514365A (en) * 1988-10-11 1996-05-07 Schiapparelli Salute S.P.A. Pharmaceutical compositions comprising calcitonin for intranasal administration
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
IT8920486A0 (en) * 1989-05-12 1989-05-12 Isf Spa PHARMACEUTICAL COMPOSITIONS.
JPH078806B2 (en) * 1990-08-16 1995-02-01 旭化成工業株式会社 Nasal emulsion containing calcitonin
IT1242019B (en) * 1990-11-20 1994-02-02 Ripari Gero Ist Farm Biolog CALCITONIN-BASED AQUEOUS PHARMACEUTICAL COMPOSITIONS, TO BE ADMINISTERED NASAL.
US5093105A (en) * 1991-04-09 1992-03-03 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats
US5306482A (en) * 1991-04-09 1994-04-26 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats
US5227152A (en) * 1991-04-09 1993-07-13 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats
DE4117078A1 (en) * 1991-05-25 1992-11-26 Boehringer Ingelheim Kg METHOD FOR PRODUCING THERAPEUTICALLY APPLICABLE AEROSOLS
DE4222647A1 (en) * 1991-07-15 1993-01-21 Sandoz Ag PEPTIDE PREPARATIONS
GR1001447B (en) * 1992-12-08 1993-12-30 Ron Poulenk Rorer Anonymos Emp Pharmaceutical products for the endonosal administration of caltcitonine.
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
US5514670A (en) * 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides
ES2137551T3 (en) 1994-11-17 1999-12-16 Alza Corp DEVICE TO IMPROVE THE ADMINISTRATION OF AN AGENT BY ELECTROTRPORTATION.
DE726075T1 (en) * 1995-02-08 1996-12-12 Therapicon Srl Non-inorganic pharmaceutical saline solutions for endonasal administration
US5759583A (en) * 1995-08-30 1998-06-02 Syntex (U.S.A.) Inc. Sustained release poly (lactic/glycolic) matrices
AU2862600A (en) * 1999-01-29 2000-08-18 Phylomed Corporation Buccal delivery system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB763168A (en) * 1953-12-31 1956-12-12 Abbott Lab Inhalant preparation
GB1213985A (en) * 1967-03-29 1970-11-25 Ransomes Sims & Jefferies Ltd Improvements in combine harvesters
GB1354526A (en) * 1971-04-19 1974-06-05 Armour Pharma Preparation for obtaining diuresis in animals
MX3864E (en) * 1975-05-27 1981-08-26 Syntex Corp A PROCESS TO PREPARE THE CRYSTALLINE COMPOUND 6-FLUIRO-11B 21-DIHIROXI-16 17-ISOPROPILIDENDIOXIPREGNA-1 4-DIEN-3 20-DIONA
GB1592513A (en) * 1977-10-28 1981-07-08 Okido Y Multipurpose tooth cleaner

Also Published As

Publication number Publication date
GB2127689A (en) 1984-04-18
GB2127689B (en) 1986-07-09
GB8326436D0 (en) 1983-11-02

Similar Documents

Publication Publication Date Title
HK27389A (en) Galenic compositions comprising calcitonin and their use
CY1466A (en) Galenic compositions comprising calcitonin and their use
DE3372705D1 (en) Pharmaceutical composition and its use
DE3365458D1 (en) Photopolymerizable compositions and their use
GB8334586D0 (en) Oral composition and abrasive
PH17562A (en) 2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions
DE3374569D1 (en) Siloxane-polyester compositions and use thereof
GB2120265B (en) Polysaccharides their preparation and therapeutic compositions containing them
NZ209095A (en) Piperidinoquinazolines and pharmaceutical compositions
NZ208669A (en) Human calcitonin 2, and pharmaceutical compositions
DE3367089D1 (en) 3-phenoxy-1-azetidinecarboxamides and their use and preparation
DE3372983D1 (en) Radiation-sensible coating composition and its use
DE3379067D1 (en) Hydrochloric acid compositions and their use
NZ208244A (en) Phenyl-pyrazol-3-ones and pharmaceutical compositions
ZA837451B (en) Galenic compositions comprising calcitonin and their use
GB2121424B (en) Waterproofing compositions their preparation and their use
DE3361451D1 (en) Fungicidal cyanopropenoates and compositions containing them
IL70379A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them
NZ205732A (en) Thiatriazine derivatives and pharmaceutical compositions
PH22848A (en) 3,3-dialkyl- and 3,3,-alkylene-indoline derivatives, pharmaceutical compositions comprising them and their use
NZ203649A (en) 2-beta-d-ribofuranosylselenazole-4-carboxamide derivatives and pharmaceutical compositions
PH21779A (en) Sulfonomidines and pharmaceutical compositions containing the same
GB2126230B (en) Substituted 1-pyridyloxy-3-indolylalkylamino-2-propanols preparation and use thereof
IL68668A0 (en) Piperidinoquinazolines and pharmaceutical compositions containing them
ZA832811B (en) Azabicyclobenzamides their preparation and their pharmaceutical compositions